Genotropin
Sponsors
Pfizer, Ludwig-Maximilians - University of Munich, Ferring Pharmaceuticals, Max-Planck-Institute of Psychiatry, Joe Springer
Conditions
AcromegalyAdult Growth Hormone DeficiencyBrain InjuriesGHDGrowth DisordersGrowth Hormone DeficiencyHormone DeficiencyISS
Phase 1
Phase 2
Hormone Treatment in Growth Hormone and Testosterone Deficient Patients
TerminatedNCT01397500
Start: 2011-11-30End: 2015-03-31Updated: 2016-01-11
Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients
CompletedNCT01822340
Start: 2011-10-31End: 2016-02-29Updated: 2016-02-19
Individualizing Dose of Growth Hormone to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in Children
CompletedNCT02879747
Start: 2003-12-31End: 2017-12-31Updated: 2019-04-30
A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9
CompletedNCT02946606
Start: 2015-01-31End: 2016-12-30Updated: 2017-09-07
Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone Deficiency
CompletedNCT03309891
Start: 2016-01-18End: 2019-05-15Updated: 2020-04-20
Phase 3
Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age
CompletedNCT00174408
Start: 1990-03-31End: 2005-02-28Target: 110Updated: 2007-05-03
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
CompletedNCT00396097
Start: 2006-12-31End: 2012-08-31Updated: 2016-04-05
Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis
CompletedNCT00420251
Start: 1996-03-31End: 2006-07-31Target: 50Updated: 2007-01-11
A Study of Zomacton in Children With Growth Hormone Deficiency
CompletedNCT00884000
Start: 2010-01-31End: 2012-07-31Updated: 2012-07-17
Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome
CompletedNCT02204163
Start: 2014-06-30End: 2017-12-31Updated: 2019-06-27
Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD
CompletedNCT03831880
Start: 2019-02-07End: 2020-08-28Updated: 2021-10-14
Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone Deficiency
CompletedNCT03874013
Start: 2017-12-07End: 2020-03-06Updated: 2021-08-12
A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency
NCT06007417
Start: 2023-12-01End: 2025-08-01Target: 162Updated: 2023-09-11
Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.
RecruitingNCT07226089
Start: 2026-02-01End: 2028-01-01Target: 254Updated: 2026-04-30